Capricorn Fund Managers LTD Roivant Sciences Ltd. Call Options Transaction History
Capricorn Fund Managers LTD
- $262 Million
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ROIV
# of Institutions
364Shares Held
456MCall Options Held
8.36MPut Options Held
760K-
Sb Investment Advisers (Uk) LTD London, X060MShares$1.03 Billion5.36% of portfolio
-
Morgan Stanley New York, NY44.7MShares$765 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$673 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$605 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$586 Million1.22% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $12.1B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...